Presentation from VMD on AMR policy and current developments
The group was briefed on the Government’s Antimicrobial Resistance (AMR) policy in relation to animal health by a member of Veterinary Medicines Directorate’s (VMD) AMR Team. The presentation covered an update on UK AMR policy and the EU Commission AMR action plan published in 2011 which set out 12 actions the EU would be concentrating on, 5 of which were veterinary related. These were to:
• strengthen the regulatory framework on the use of veterinary medicines;
• recommend the introduction of prudent use (non-mandatory) guidance, expected to be published in approximately 6 months’ time;
• introduce a new Animal Health Law;
• request more advice on the impact of new antibiotics on animal and human health;
• strengthen surveillance systems including the new harmonized monitoring Decision.
Members were updated on recent changes to EU legislation and on the goals of the Government AMR Strategy 2013-2018 which was launched in September 2013.
Members noted that as expanding surveillance data was one of the areas for action, it was important that there were clear objectives in carrying out surveillance so that it achieved whatever it was supposed to achieve, for example identifying new and emerging problems, monitoring the impact of interventions or analysing specific issues.